A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
On June 22-23, we were at the annual Becker’s Spine, Ortho and Pain conference in Chicago and talking about how we’re demonstrating that measured, precise and pre-emptive care generates real ROI. Interested in learning more or furthering our discussions? Contact us at info@om1.com.
At the forefront of a growing movement towards value-based care, orthopaedic surgeons are facing increasing pressure to make better decisions based on outcomes; to assume greater risk for the cost of joint replacement patient care; and to reduce overall costs while demonstrating quality improvement. Join us for a webinar addressing emerging initiatives, technologies and best[…]
Value-based care is gaining momentum and with that so too are outcomes-based contracts and risk sharing agreements. As payment models increasingly link outcomes to payment, there is a greater need for alignment of outcomes among different stakeholders. Join Dr. Richard Gliklich as he discusses the opportunities and challenges with: Defining measurable outcomes Developing and implementing[…]
New payment models require health care organizations to make better decisions about outcomes, Richard Gliklich says December 8, 2016 – Richard Gliklich, M.D. – H&HN Magazine Health care is the largest part of the national economy, and the costs of maintaining it are growing at an unsustainable rate. As a result, Medicare and other payers[…]
